ArticleJHEP reports : innovation in hepatology2020

Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.

Morgane Van Wettere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.